The MENA Biologics & Biosimilars market is estimated to be...

added article Other

2023-08-22 13:17:34 -

The MENA Biologics & Biosimilars market is estimated to be valued at US$442.5 million in 2020 and is expected to exhibit a CAGR of 3.9% over the forecast period of 2022-2030

Market Overview:The MENA Biologics & Biosimilars market is estimated to be valued at US$442.5 million in 2020 and is expected to exhibit a CAGR of 3.9% over the forecast period of 2022-2030, according to a new report published by Coherent Market Insights. Biologics and biosimilars are complex molecules derived from living cells and are used in the treatment of various chronic diseases such...

0 Comments 0 Shares 1420 Views 0 Reviews